(c) 2024 PillSync.com

fluoxetine 20 mg oral tablet

1 INDICATIONS & USAGE Fluoxetine is a selective serotonin reuptake inhibitor indicated for: Acute and maintenance treatment of Major Depressive Disorder (MDD) in adult and pediatric patients aged 8 to 18 years (1.1) Acute and maintenance treatment of Obsessive Compulsive Disorder (OCD) in adults and pediatric patients aged 7 to 17 years (1.2) Acute and maintenance treatment of Bulimia Nervosa in adult patients (1.3) Acute treatment of Panic Disorder, with or without agoraphobia, in adult patients (1.4) Indication Adult Pediatric MDD (2.1) 20 mg/day in am (initial dose) 10 to 20 mg/day (initial dose) OCD (2.2) 20 mg/day in am (initial dose) 10 mg/day (initial dose) Bulimia Nervosa (2.3) 60 mg/day in am Panic Disorder (2.4) 10 mg/day (initial dose) A lower or less frequent dosage should be used in patients with hepatic impairment, the elderly, and for patients with concurrent disease or on multiple concomitant medications (2.7) 1.1 Major Depressive Disorder Fluoxetine is indicated for the acute and maintenance treatment of Major Depressive Disorder in adult patients and in pediatric patients aged 8 to 18 years [see Clinical Studies (14.1)] . The usefulness of the drug in adult and pediatric patients receiving fluoxetine for extended periods should periodically be re-evaluated [see Dosage and Administration (2.1)] . 1.2 Obsessive Compulsive Disorder Fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with Obsessive Compulsive Disorder (OCD) [see Clinical Studies (14.2)] . The effectiveness of fluoxetine in long‑term use, i.e., for more than 13 weeks, has not been systematically evaluated in placebo‑controlled trials. Therefore, the physician who elects to use fluoxetine for extended periods should periodically re-evaluate the long‑term usefulness of the drug for the individual patient [see Dosage and Administration (2.2)] . 1.3 Bulimia Nervosa Fluoxetine is indicated for the acute and maintenance treatment of binge‑eating and vomiting behaviors in adult patients with moderate to severe Bulimia Nervosa [see Clinical Studies (14.3)] . The physician who elects to use fluoxetine for extended periods should periodically re-evaluate the long‑term usefulness of the drug for the individual patient [see Dosage and Administration (2.3)] . 1.4 Panic Disorder Fluoxetine is indicated for the acute treatment of Panic Disorder, with or without agoraphobia, in adult patients [see Clinical Studies (14.4)] . The effectiveness of fluoxetine in long‑term use, i.e., for more than 12 weeks, has not been established in placebo‑controlled trials. Therefore, the physician who elects to use fluoxetine for extended periods should periodically re-evaluate the long‑term usefulness of the drug for the individual patient [see Dosage and Administration (2.4)] .

par pharmaceutical, inc.


4 years ago OVAL WHITE E P 362 fluoxetine 20 mg oral tablet

OVAL WHITE E P 362

4 years ago OVAL WHITE E P 362 fluoxetine 20 mg oral tablet

E P 362 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 HOW SUPPLIED Fluoxetine tablets, USP is available as follows: 10 mg*, white to off-white film-coated, oval shaped tablets, functionally scored and debossed with “E” and “P” on one side and 360 on the other side. Bottles of 30 NDC 49884-335-11 Bottles of 100 NDC 49884-335-01 Bottles of 1000 NDC 49884-335-10 Bottles of 2000 NDC 49884-335-82 20 mg*, white to off-white film-coated, oval shaped tablets, functionally scored and debossed with “E” and “P” on one side and 362 on the other side. Bottles of 30 NDC 49884-336-11 Bottles of 100 NDC 49884-336-01 Bottles of 1000 NDC 49884-336-10 Bottles of 1000 NDC 49884-336-82 *Fluoxetine base equivalent. 16.2 STORAGE AND HANDLING Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].


More pills like OVAL E P 362

Related Pills

Fluoxetine 10 MG Oral Tablet

Par Pharmaceutical, Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site